Investments
24Portfolio Exits
6
Want to inform investors similar to Mass Medical Angels about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Mass Medical Angels News
Aug 15, 2018
Capillary Biomedical, Inc. , an Irvine, Calif.-based developer of a novel infusion set for use with insulin pumps for the intensive management of diabetes, raised $2.9m in a seed funding. The round was led by the Cove Fund with participation by a broad syndicate of Angel Groups and accredited investors Tech Coast Angels, New York Angels, HBS Alumni Angels of New York, Pasadena Angels, the Mass Medical Angels, the ACE Fund, PA Fund and NYA Fund. The company intends to use the funds for clinical studies to support an initial 510(k) filing and preparation for market launch in 2019. Led by Co-founder Professor Jeffrey Joseph of the Sidney Kimmel Medical College at Thomas Jefferson University, CEO Paul Strasma, VP of Sales and Marketing Mark Estes, CapBio has developed the SteadiSettm infusion set with SteadiFlowtm technology, a patented design that addresses several key failure points with current infusion sets that affect the health, quality of life, and cost for the 1.2 million worldwide insulin pump users. The core cannula technology was developed by Dr. Joseph at the Jefferson Artificial Pancreas Center of Thomas Jefferson University with grant funding from the National Institutes of Health and JDRF, the global organization funding Type 1 diabetes research. FinSMEs 15/08/2018
Mass Medical Angels Investments
24 Investments
Mass Medical Angels has made 24 investments. Their latest investment was in Pykus Therapeutics as part of their Seed VC on February 2, 2021.

Mass Medical Angels Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
2/5/2021 | Seed VC | Pykus Therapeutics | $2.49M | Yes | Mass Medical Angels, Partners Innovation Fund, and Undisclosed Investors | 1 |
12/10/2020 | Series A | Astrocyte Pharmaceuticals | $6M | Yes | 2 | |
8/14/2018 | Seed VC | Capillary Biomedical | $2.9M | Yes | 4 | |
4/4/2017 | Series A | |||||
8/3/2015 | Series B - III |
Date | 2/5/2021 | 12/10/2020 | 8/14/2018 | 4/4/2017 | 8/3/2015 |
---|---|---|---|---|---|
Round | Seed VC | Series A | Seed VC | Series A | Series B - III |
Company | Pykus Therapeutics | Astrocyte Pharmaceuticals | Capillary Biomedical | ||
Amount | $2.49M | $6M | $2.9M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Mass Medical Angels, Partners Innovation Fund, and Undisclosed Investors | ||||
Sources | 1 | 2 | 4 |
Mass Medical Angels Portfolio Exits
6 Portfolio Exits
Mass Medical Angels has 6 portfolio exits. Their latest portfolio exit was Capillary Biomedical on July 21, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/21/2022 | Acquired | 2 | |||
Date | 7/21/2022 | ||||
---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Mass Medical Angels Team
4 Team Members
Mass Medical Angels has 4 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
Richard Anders | Founder | Current | |
Name | Richard Anders | |||
---|---|---|---|---|
Work History | ||||
Title | Founder | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.